SI1321471T1 - - Google Patents
Info
- Publication number
- SI1321471T1 SI1321471T1 SI200330035T SI200330035T SI1321471T1 SI 1321471 T1 SI1321471 T1 SI 1321471T1 SI 200330035 T SI200330035 T SI 200330035T SI 200330035 T SI200330035 T SI 200330035T SI 1321471 T1 SI1321471 T1 SI 1321471T1
- Authority
- SI
- Slovenia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03290605A EP1321471B1 (fr) | 2003-03-12 | 2003-03-12 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1321471T1 true SI1321471T1 (pt) | 2005-08-31 |
Family
ID=8185877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200330035T SI1321471T1 (pt) | 2003-03-12 | 2003-03-12 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1321471B1 (pt) |
| AR (1) | AR043567A1 (pt) |
| AT (1) | ATE294814T1 (pt) |
| DE (1) | DE60300581T2 (pt) |
| DK (1) | DK1321471T3 (pt) |
| ES (1) | ES2240919T3 (pt) |
| MY (1) | MY135359A (pt) |
| PT (1) | PT1321471E (pt) |
| SI (1) | SI1321471T1 (pt) |
| WO (1) | WO2004083238A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1362864E (pt) * | 2003-06-30 | 2007-07-23 | Servier Lab | Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico |
| EP1367061B1 (fr) * | 2003-06-30 | 2006-01-04 | Les Laboratoires Servier | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
| ATE338058T1 (de) * | 2003-07-31 | 2006-09-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen |
| ATE338766T1 (de) * | 2003-08-29 | 2006-09-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen |
| ATE310012T1 (de) | 2003-08-29 | 2005-12-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen |
| AU2006281684B2 (en) * | 2005-08-12 | 2012-08-02 | Lek Pharmaceuticals D.D. | A process for the preparation of perindopril erbumine |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78413B (pt) * | 1981-12-29 | 1984-09-27 | Hoechst Ag | |
| FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
| FR2827860B1 (fr) * | 2001-07-24 | 2004-12-10 | Servier Lab | Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril |
-
2003
- 2003-03-12 DK DK03290605T patent/DK1321471T3/da active
- 2003-03-12 DE DE60300581T patent/DE60300581T2/de not_active Expired - Lifetime
- 2003-03-12 SI SI200330035T patent/SI1321471T1/xx unknown
- 2003-03-12 ES ES03290605T patent/ES2240919T3/es not_active Expired - Lifetime
- 2003-03-12 PT PT03290605T patent/PT1321471E/pt unknown
- 2003-03-12 EP EP03290605A patent/EP1321471B1/fr not_active Expired - Lifetime
- 2003-03-12 AT AT03290605T patent/ATE294814T1/de active
-
2004
- 2004-03-12 MY MYPI20040880A patent/MY135359A/en unknown
- 2004-03-12 AR ARP040100804A patent/AR043567A1/es not_active Application Discontinuation
- 2004-03-12 WO PCT/FR2004/000594 patent/WO2004083238A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| PT1321471E (pt) | 2005-07-29 |
| DK1321471T3 (da) | 2005-08-29 |
| EP1321471B1 (fr) | 2005-05-04 |
| MY135359A (en) | 2008-03-31 |
| DE60300581T2 (de) | 2006-01-19 |
| ES2240919T3 (es) | 2005-10-16 |
| AR043567A1 (es) | 2005-08-03 |
| DE60300581D1 (de) | 2005-06-09 |
| ATE294814T1 (de) | 2005-05-15 |
| WO2004083238A1 (fr) | 2004-09-30 |
| EP1321471A1 (fr) | 2003-06-25 |